Phibro Animal Health (PAHC) Tops Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health Corporation Reports Second Quarter Results, Provides Revised Financial Guidance
February 9, 2022 4:25 PM ESTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its second quarter ended December 31, 2021.
Highlights for the three months ended December 31, 2021 (compared to the three months ended December 31, 2020) Net sales of $233 million, an increase of $27 million, or 13% Net income of $17 million, an increase of $5 million, or 36% Diluted EPS of $0.43, an increase of $0.11 or 34% Adjusted EBITDA of $29 million, an increase of $1 million, or... More